University of Pennsylvania

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1740-11-14

Employees: 5K

Market Cap: -

Website: http://www.upenn.edu

Clinical Trials

Variability in Response to Non-steroidal Anti-inflammatory Drugs

Phase 1

Terminated

Conditions: Healthy

Interventions: Drug: Celecoxib
Drug: Naproxen
Drug: Placebo

First Posted Date: 2015-07-17

Last Posted Date: 2023-12-13

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 16

Registration Number: NCT02502006

Locations: 🇺🇸
Institute for Translational Medicine and Therapeutics (ITMAT), University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States

Healthy In-Store Marketing Study

Not Applicable

Completed

Conditions: Obesity

Interventions: Other: Intervention stores

First Posted Date: 2015-07-16

Last Posted Date: 2021-03-09

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 33

Registration Number: NCT02499211

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Yoga Intervention for Substance Use and ART Adherence in Community Reentry

Not Applicable

Completed

Conditions: Substance Related Disorders
HIV

Interventions: Other: Hatha yoga

First Posted Date: 2015-07-09

Last Posted Date: 2017-04-18

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 72

Registration Number: NCT02492893

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Intuition vs. Deliberation in Medical Decision Making

Not Applicable

Completed

Conditions: Decision Making About Life-sustaining Treatment in Patients With Serious Cardiac, Respiratory and Oncological Conditions Likely to Limit Life Expectancy

Interventions: Behavioral: Deliberative instructions
Behavioral: Cognitive load

First Posted Date: 2015-07-02

Last Posted Date: 2019-07-19

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 200

Registration Number: NCT02487810

Locations: 🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

Increasing Engagement With a Healthy Food Benefit

Not Applicable

Completed

Conditions: Purchasing Behaviors
Nutrition

Interventions: Other: Messaging
Other: Financial incentives

First Posted Date: 2015-07-01

Last Posted Date: 2020-07-10

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 7314

Registration Number: NCT02486588

Diet and Stool Metabolites in Fecal Incontinence

Completed

Conditions: Fecal Incontinence

Interventions: Other: No Intervention

First Posted Date: 2015-06-30

Last Posted Date: 2018-04-17

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 28

Registration Number: NCT02485522

Locations: 🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

Pilot Trial of HER-2/Neu Pulsed DC1 Vaccine for Patients With HER-2 Positive Metastatic Cancer

Conditions: Metastatic Cancer

First Posted Date: 2015-06-16

Last Posted Date: 2017-08-11

Lead Sponsor: University of Pennsylvania

Registration Number: NCT02473653

Locations: 🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

Way to Cure HCV Adherence

Not Applicable

Completed

Conditions: Hepatitis C

Interventions: Behavioral: MedSignals Pill Box

First Posted Date: 2015-06-16

Last Posted Date: 2022-02-08

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 60

Registration Number: NCT02472925

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸
Corporal Michael J. Crescenz VA Medical Center, Philadelphia, Pennsylvania, United States

Ovarian Reserve After Cancer: Longitudinal Effects

Active, not recruiting

Conditions: Effects of Chemotherapy
Premature Ovarian Failure

First Posted Date: 2015-06-09

Last Posted Date: 2024-10-17

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 196

Registration Number: NCT02467231

Locations: 🇺🇸
University of Pennsylvania, Reproductive Research Unit, Philadelphia, Pennsylvania, United States

Pilot Study of Autologous T-cells in Patients With Metastatic Pancreatic Cancer

Phase 1

Terminated

Conditions: Pancreatic Cancer

Interventions: Biological: CART-meso-19 T cells
Drug: Cyclophosphamide

First Posted Date: 2015-06-09

Last Posted Date: 2019-12-16

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 4

Registration Number: NCT02465983

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy